Kim Sun-Suk, Suh Dong-Soo, Kim Ki-Hyung, Yoon Man-Soo, Choi Kyung-Un
Department of Obstetrics and Gynecology, Pusan National University College of Medicine, Busan, Korea.
Obstet Gynecol Sci. 2013 Mar;56(2):76-83. doi: 10.5468/OGS.2013.56.2.76. Epub 2013 Mar 12.
To investigate the clinical significance of atypical glandular cells (AGC) by analyzing the prevalence and histologic outcomes of patients with AGC according to Pap smear.
The medical records of 83 patients who were diagnosed AGC on Pap tests at the Pusan National University Hospital outpatient department and health care center from January 1998 to March 2006 were reviewed.
The prevalence of AGC was 55 of 54,160 (0.10%) and 28 of 54,160 (0.05%) for AGC-not otherwise specified (NOS) and neoplastic associated AGC, respectively. The histopathologic results of the AGC-NOS group (n=55) were as follows: low-grade squamous intraepithelial lesion, 7 (12.7%); high-grade squamous intraepithelial lesion, 4 (7.2%); adenocarcinoma of cervix, 3 (5.4%); endometrial carcinoma, 2 (3.6%); and other malignancies including 2 ovarian cancer cases and 1 breast cancer case, 3 (5.4%). The histopathologic results for the AGC-associated neoplastic group (n=28) were as follows: low-grade squamous intraepithelial lesion, 1 (3.5%); high-grade squamous intraepithelial lesion, 3 (10.7%); adenocarcinoma of cervix, 5 (17.8%); endometrial carcinoma, 4 (4.8%); and additional malignancies including 3 stomach cancer cases, 2 ovarian cancer cases, and 2 breast cancer cases; 7 (25%).
AGCs may represent a variety of benign and malignant lesions. AGC-associated neoplastic findings may be related to gynecological or extrauterine malignancies. Thus, when AGCs, especially neoplastic AGCs, are encountered, it is best to evaluate the cervix not only for typical maladies, but also for gynecological and non-gynecological malignancies.
通过分析巴氏涂片检查中不典型腺细胞(AGC)患者的患病率和组织学结果,探讨AGC的临床意义。
回顾了1998年1月至2006年3月在釜山国立大学医院门诊部和保健中心接受巴氏试验诊断为AGC的83例患者的病历。
AGC的患病率为54160例中的55例(0.10%),其中未另行指定(NOS)的AGC为54160例中的28例(0.05%),与肿瘤相关的AGC分别为54160例中的28例(0.05%)。AGC-NOS组(n=55)的组织病理学结果如下:低级别鳞状上皮内病变,7例(12.7%);高级别鳞状上皮内病变,4例(7.2%);宫颈腺癌,3例(5.4%);子宫内膜癌,2例(3.6%);其他恶性肿瘤包括2例卵巢癌和1例乳腺癌,3例(5.4%)。AGC相关肿瘤组(n=28)的组织病理学结果如下:低级别鳞状上皮内病变,1例(3.5%);高级别鳞状上皮内病变,3例(10.7%);宫颈腺癌,5例(17.8%);子宫内膜癌,4例(4.8%);其他恶性肿瘤包括3例胃癌、2例卵巢癌和2例乳腺癌;7例(25%)。
AGC可能代表多种良性和恶性病变。AGC相关的肿瘤发现可能与妇科或子宫外恶性肿瘤有关。因此,当遇到AGC,尤其是肿瘤性AGC时,最好不仅对宫颈进行典型疾病评估,还要对妇科和非妇科恶性肿瘤进行评估。